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Fungal arteritis is a rare entity, associated with significant morbidity and mortality, that typically involves
graft arteries in solid organ transplant recipients. Here, we report the first case of Candida carotid arteritis
and review 22 other cases of Candida arteritis reported since 1966 in patients who have not received transplants.
Most patients had serious underlying conditions. All cases were anatomically characterized by pseudoaneurysm
formation. Patients presented with fever ( ), local pain ( ), and an expanding pulsatile massnp 17 np 13
( ), with subsequent rupture and hemorrhage ( ). Evidence of Candida colonization or infectionnp 4 np 7
was present in 15 patients before arteritis occurred. Treatment typically included a combined surgical and
antifungal approach. The outcome was favorable in 11 patients, but follow-up was limited. A high index of
suspicion, early diagnosis, and prompt antifungal and surgical treatment seem crucial to efforts to avoid life-
threatening arterial rupture and hemorrhage.
The term “mycotic endarteritis” was coined by Osler
[1] in 1885 to indicate infection of blood vessel walls
due to septic embolization in patients with infectious
endocarditis. This term is a misnomer, because the vast
majority of arterial aneurysm infections are bacterial in
origin [2–4], typically occurring in the context of ar-
terial trauma due to injection drug use [5] or cardio-
genic bacterial emboli.
Arterial infection associated with Candida species is
an emerging problem in solid organ transplant (SOT)
recipients, in whom it generally occurs as anastomotic
site infection of graft vessels [5–8]. In several cases, the
infection has been transmitted from the donor, most
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often via contaminated kidney graft infusate (reviewed
in [8]). Graft loss and/or severe hemorrhage are com-
mon complications [6, 7, 9–13]. In addition to SOT
recipients, 22 cases of Candida arteritis in patients who
have not received SOTs have been published [2, 3, 7,
13–22]. Here, we report the first case, to our knowledge,
of carotid arteritis due to Candida albicans and review
the 22 published non-SOT cases, to describe the clinical
and microbiological features of this entity.
METHODS
We searched the PubMed database (1966–2006; all lan-
guages) using the terms “candida,” “pseudoaneurysm,”
“aneurysm,” and “arteritis.” Cases were considered to
be definite if yeast elements were present microscopi-
cally, if Candida was grown in culture of a surgical
artery-wall specimen or vascular graft [2, 3, 6, 8–10,
14–18, 20, 23–31], or if Candida organisms were pre-
sent in culture of an aneurysm vegetation [32]. Prob-
able cases were defined as those in patients with can-
didemia who had radiographic evidence of a new
vascular (pseudo)aneurysm, in the absence of other
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compatible pathogens in blood or artery-wall culture [4, 6,
33, 34].
Six possible cases were excluded from our review: 4 were in
patients who had polymicrobial infection; thus, it was unclear
which symptoms and signs were attributable to Candida and
which were due to the other organism [19, 35–37]. Two cases
were excluded because Candida organisms were cultured from
the urine or other sites but not from the blood or artery wall
[38, 39].
CASE REPORT
A 75-year-old man presented in December 2002 with hoarse-
ness and an enlarging, painful, pulsatile mass in the right side
of his neck. He had end-stage diabetic and hypertensive ne-
phropathy and had been hemodialysis dependent for the pre-
vious 5 years, with an arteriovenous prosthesis of the forearm
in place. The patient had severe peripheral arterial disease, with
multiple previous arterial leg bypass operations and with en-
doscopic insertion, in August 2002, of an intra-arterial pros-
thesis because of an internal iliac aneurysm. Ultrasound ex-
amination of the neck mass showed a pseudoaneurysm of the
right common carotid. Surgical resection and insertion of a
prosthetic graft was done. Two days later, pneumonia and
empyema due to Enterobacter cloacae developed, which was
treated with chest tube drainage and imipenem administered
intravenously.
Histologic analysis of the endarterectomy material showed
an ulcerated, calcified atheromatous plaque involving the ar-
terial intima and media. The plaque was surrounded by fibro-
muscular tissue displaying chronic inflammation, including
lymphocytes, macrophages, and giant cells. Pseudohyphae were
seen, and C. albicans grew after 5 days in culture of the resected
arterial specimens. Culture results were negative for bacteria.
Serum candidal antimannan antibodies were positive (41.2 ng/
mL; normal, !5 ng/mL). Five sets of blood cultures did not
reveal any growth. Fluconazole treatment (200 mg once daily
by mouth) was initiated with a plan for long-term treatment
because of the prosthetic graft. Two months after the operation,
the patient had a cardiopulmonary arrest in the setting of severe
hyperkalemia, with no fever or other symptoms suggesting per-
sistent fungal infection. The patient died. Permission to per-
form an autopsy was not granted.
RESULTS
Since the first description of a case of femoral artery-wall in-
fection due to Candida species, by Anderson in 1974 [20], 39
cases of Candida arteritis have been described in the literature.
Of these cases, 17 occurring in SOT recipients have recently
been reviewed [8]. In addition to the case described in the
above section, 19 definite and 3 probable cases [4, 33, 34]
occurring outside of the SOT setting are the subject of this
review (table 1). The mean age of patients was 46 years (range,
1 month–80 years), and 17 patients were male. Clinical pre-
sentations included fever ( ), local pain ( ), an ex-np 17 np 15
panding pulsatile mass ( ), and major hemorrhage (np 5 np
). Candida arteritis occurred in 3 patients admitted to the7
intensive care unit, of whom 2 received mechanical ventilation.
The arteries involved were the thoracic aorta or its branches
( ), intracranial arteries ( ), the abdominal aortanp 5 np 3
( ), the iliac artery ( ), the femoral artery ( ),np 8 np 2 np 3
and 1 case each in the pulmonary, brachial, popliteal, and ti-
bioperoneal arteries. In 2 cases, 2 different arteries were in-
volved (the abdominal aorta and brachial artery in one case
and the popliteal and tibioperoneal arteries in the other). Native
arteries were infected in 19 cases, whereas a prosthetic arterial
graft was infected in 2 cases [15, 29], a vein graft was infected
in 1 case [14], and an aortic homograft was infected in 1 case
[34].
Potentially contributory conditions included advanced can-
cer ( ), diabetes mellitus ( ), major surgery ( ),np 5 np 4 np 4
injection drug use ( ), end-stage renal disease/hemodial-np 3
ysis ( ), advanced HIV infection ( ), and long-termnp 2 np 2
corticosteroid treatment ( ). An underlying vascular dis-np 2
ease was documented in only 4 patients, including the patient
described in the present article [5, 17, 25].
Candidemia was recorded in 11 of 22 cases for which blood
cultures were performed. Seven patients had endocarditis doc-
umented (4 native valve and 3 prosthetic valve). Seven patients
had candiduria; in each case, it is unclear whether this repre-
sented the source or a consequence of candidemia. One patient
had concomitant Candida arthritis. An infected intravenous
catheter was diagnosed in 2 cases.
Fifteen of 23 patients had a documented Candida infection
or colonization before the diagnosis of Candida arteritis: 9
patients had candidemia, 4 patients had mucocutaneous or
respiratory Candida infection or colonization, 1 patient had
candiduria, and 1 patient had a proven Candida spondylodis-
kitis 4 months before the diagnosis of fungal aortitis.
Candida arteritis was diagnosed by direct, microscopic ex-
amination ( ) or via growth in culture from surgical ar-np 11
tery-wall specimens ( ). The cultured Candida speciesnp 21
included C. albicans ( ), C. tropicalis ( ), C. par-np 14 np 1
apsilosis ( ), and Candida not further specified ( ).np 1 np 5
Pathologic examination of resected surgical tissue showed an
inflammatory infiltrate in the 11 patients with histologic results
reported, and direct tissue examination revealed yeast elements
in all of these cases.
Treatment included antifungal therapy alone ( ) ornp 1
combined with surgery ( ). Multiple antifungal regimensnp 18
were used (table 1), including amphotericin B ( ), am-np 7
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Table 1. Clinical features of 23 reported cases of Candida arteritis in patients who have not undergone solid organ transplantation.
Case type, reference Age,a sex Underlying conditions Clinical features Artery involved
Native
artery/prosthetic
graft
Definite cases
Thomas et al. [14] 29, M Advanced HIV infection, IDU Pulsatile popliteal mass, local pain Femoropopliteal
vein graft
Vein graft
Cooley and Bur-
nett [15]
46, M Dacron graft for aortic dissection;
extensive bowel resection
Fever, chills and malaise, back pain Aortic dacron graft PG
Mahesh et al. [29] 35, M Marfan syndrome with dilatation of the
aortic root
Fever, pseudoaneurysm of aortic pros-
thetic root (6 weeks after surgery)
Aortic graft PG
Barry et al. [16] 80, F DM Fever, melena, abdominal pain,
weight loss
Abdominal aorta Native
Manso et al. [2] 35, M IDU, HIV seronegative Chest pain, fever, chills, hemorrhage Descending thoracic aorta Native
Ikeda et al. [3] 63, M Esophageal carcinoma, broad-spectrum
antibiotics
Abdominal pain, fatigue, fever,
hemorrhage
Abdominal aorta Native
Marty-Ane´ et al.
[23]
73, M Colonic polyp resection 7 months before Abdominal pain, diarrhea, fever, tender
pulsatile epigastric mass
Abdominal aorta Native
Roush et al. [24] 62, M CHF, abdominal surgery Fever, sweats, dyspnea, cough,
hemorrhage
Pulmonary artery Native
Rubin and
German [25]
71, M DM, radical cystectomy (transitional cell
carcinoma)
Low abdominal pain Abdominal aorta Native
Woodrum et al.
[5]
49, M DM Pain, knee swelling Right common iliac artery Native
Minami et al. [26] 68, M Steroid therapy (uveitis) Back pain, fever Aortic arch Native
Tsunezuka et al.
[17]
70, M Gastric cancer Fever, anorexia, pulsatile mass Common iliac artery Native
Goldman et al.
[27]
16, F SLE, prednisone Headache, fever, irritability, seizures,
subarachnoid hemorrhage
Proximal basilar artery Native
Takeda et al. [18] 67, M Intestinal cancer Fever, hemiparesis, coma, subarachnoid
hemorrhage
Right middle cerebral
artery
Native
Gladstone et al.
[32]
31, F Hysterectomy (carcinoma of the cervix),
prior IDU
Fever, pain and coldness of the right foot Right superficial femoral
artery
Native
Anderson et al.
[20]
26, F ESRD, HD Fever, pain, pulsatile mass Common femoral artery Native
Oderich et al. [28] NR Primary aortoduodenal fistula NR Juxtarenal aorta NR
Collins et al. [31] 20, M None Fever, headache, right hemiparesis,
upper arm pain
Brachial artery, abdominal
aorta
Native
Rabah et al. [30] 11 months, F AIDS (CD4 cell count, 6 cells/mm3) Prolonged fever, seizures, left arm
stiffness, hemorrhage
Basilar meningeal arteries Native
Present article 75, M ESRD/HD, DM Expanding pulsatile neck mass, pain Carotid Native
Probable cases
Zedtwitz-Lieben-
stein et al. [34]
46, M Homograft aortic valve replacement Fever, night sweats Ascending aorta Native
Larena-Avellaneda
et al. [4]
53, M Candida prosthetic endocarditis Fever, local pain, leg abscess with
compartment syndrome
Popliteal and tibiopero-
neal artery
Native
Khoss et al. [33] 32 days, M Prematurity Apnea, abdominal distension Abdominal aorta Native
NOTE. 5FC, flucytosine; AmB, amphotericin B; CHF, congestive heart failure; CVA, cerebrovascular accident; DM, diabetes mellitus; ESRD, end-stage renal
disease; HD, hemodialysis; IV, intravenous; IDU, injection drug use; L-AmB, liposomal amphotericin B; NR, not reported; PG, prosthetic graft; SLE, systemic
lupus erythematous; UTI, urinary tract infection.
a Age is given in years, unless otherwise specified.
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Table 1. (Continued.)
Histologic
evidence of
fungal invasion
Artery-wall
culture results
(source of specimen)
Candidemia/
endocarditis Candiduria
IV
catheter infection Treatment (duration)
Outcome,
comments
+ Candida albicans
(vein graft)
+/ NR NR Surgery, AmB plus 5FC (1
month), then fluconazole
Pseudoaneurysm over
vein graft
NR C. albicans
(artery graft)
+/NR NR NR Surgery, L-AmB (2
months), then
fluconazole
Died (9 months after of fungal
infection)
NR C. albicans,
aortic graft
+/+ + NR Surgery, AmB plus 5FC (6
weeks), then fluconazole
Favorable evolution
 C. albicans
(aortic wall)
/NR Vaginal
Candida infection
NR Surgery, fluconazole Died (7 days after aortitis was
diagnosed, of pneumonia
and stroke); duodenal perfo-
ration association (probable
aortoenteric fistula)
NR C. albicans
(aortic wall)
/NR  NR Surgery, L-AmB Mucocutaneous candidiasis
3 months before aortitis
 Candida species
(aortic wall)
+ (11 months
before aortitis)/
NR
+ + Surgery, IV miconazole,
then unspecified oral an-
tifungal treatment
…
NR C. albicans (aortic
wall)
+ (after polyp re-
section)  (at
index admis-
sion)/NR
NR NR Surgery, AmB, then life-
long fluconazole
C. albicans spondylodiskitis
4 months before index
admission
+ C. albicans (tricus-
pide valve and pul-
monary artery)
+/+ NR Swan-Ganz
1 year before
Surgery, AmB plus 5FC Died (day 11 of antifungal
treatment) of massive
pulmonary hemorrhage
+ Candida species
(aortic wall)
+ (6 weeks be-
fore aortitis)/
NR
+ … Surgery, AmB, then life-
long fluconazole
Mechanical obstruction of ure-
teral stents with Candida
species 8 weeks before
aortitis
+ C. albicans
(artery wall)
/NR + NR Surgery, AmB (4 weeks) Intermittent fungal UTI
+ C. albicans
(aortic wall)
/NR NR NR Surgery, fluconazole,
itraconazole
…
 C. albicans
(artery wall)
/NR NR +
(2 years before arteritis)
Surgery, fluconazole
(1 year)
Candidemia 2 years before
+ C. albicans
(artery wall)
/ + NR … Necropsy diagnosis; ventricular
shunt culture positive for
C. albicans 3 days before
death; oral thrush
+ Candida species
(artery wall and
mitral valve)
NR/+ NR NR … Necropsy diagnosis
NR Candida parapsilosis
(artery wall
vegetation)
+/+ (mitral
endocarditis)
NR NR Surgery, AmB plus 5FC Died of pneumonia (10 months
after arteritis)
+ Candida species
(artery wall)
NR/NR NR NR Surgery, AmB Operative groin wound from
vaginal candidiasis
NR Candida species
(artery wall)
/NR NR NR Surgery, unspecified anti-
fungal therapy (4
months)
Prosthetic graft infection
9 months after surgery; died
(11 months after CVA)
+  /+ (mitral
endocarditis)
NR NR Surgery, AmB …
+ NR / +  … Necropsy diagnosis; arteriopa-
thy associated with chronic
meningitis
+ C. albicans (carotid
artery wall)
/NR  … Surgery, fluconazole Died of hyperkaliemia
(2 months after arteritis
was diagnosed)
NR  + (Candida
tropicalis)/+
(prosthetic aor-
tic valve)
NR NR Surgery, 5FC plus flucona-
zole (1 week), then AmB
(45 days)
…
  + (C. albicans)/+ NR NR Surgery, AmB plus 5FC
plus fluconazole, then
fluconazole (6 months)
Recovery; no valvular
replacement
  + (C. albicans)/NR + Umbilical vein catheter AmB plus 5FC Died (42nd day of life)
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photericin B combined with flucytosine ( ), fluconazolenp 4
alone ( ), amphotericin B combined with both flucytosinenp 3
and fluconazole ( ), fluconazole and itraconazole (np 2 np
), and miconazole alone ( ). No patient underwent sur-1 np 1
gical management without antifungal treatment. Of the 7 pa-
tients with diagnoses of Candida endocarditis, 5 underwent
valve replacement and antifungal therapy, and 1 was treated
medically; 1 case was diagnosed postmortem.
Overall mortality was high; 9 of 23 patients died. In 3 cases
[16, 28, 32], death was believed to be not related to the Candida
infection. In all patients with intracranial arteritis, the diagnosis
was made postmortem.
DISCUSSION
Here we present the first case, to our knowledge, of Candida
carotid arteritis and review the literature regarding 22 additional
cases of Candida arteritis that occurred outside of the SOT
setting. Patients typically presented with pain at the site of the
infected artery and with fever. Documented underlying vascular
disease was surprisingly infrequent. The source of Candida in-
fection usually remained obscure, even though, in the majority
of patients, Candida colonization or infection was present be-
fore Candida arteritis was diagnosed. All patients except 1 had
serious concomitant conditions that were similar to those as-
sociated with invasive candidiasis [16, 25]. Mortality was high;
death was most commonly due to arterial rupture and massive
hemorrhage, particularly when aortic or intracranial vessels
were involved in the infection.
In all cases, pseudoaneurysms of the infected artery were
present. Two mechanisms have been suggested to explain fungal
arteritis [20, 23]. First, infection of a preexisting atherosclerotic
aneurysm might occur during an episode of candidemia; this
was suggested in our patient by the atherosclerotic degeneration
seen histologically in the surgical carotid specimen and the
absence of endocarditis. Alternatively, localized Candida infec-
tion of the artery wall (typically via septic microemboli to the
vasa vasorum of the artery wall or septic embolization in an
artery, or from a contiguous infectious process extending to a
nearby artery) may be followed by weakness of the artery wall
and secondary pseudoaneurysm formation. It is conceivable
that these 2 mechanisms coexist. The relative rarity of preex-
isting arterial disease in published cases suggests that the second
mechanism may be more important.
Only half of the patients with Candida arteritis had docu-
mented candidemia. This is consistent with the well-recorded
difficulty of premortem detection of candidemia in patients
who are found to have disseminated candidiasis at autopsy [40].
When Candida arteritis is diagnosed, potential complications
of candidemia (including endocarditis, endophthalmitis, and
spondylodiskitis) should be searched for, even when blood cul-
ture results are negative. Another major complication of Can-
dida arteritis is massive hemorrhage, perhaps because infected
aneurysms are more prone to rupture than are atherosclerotic
aneurysms. The diagnosis of Candida arteritis was frequently
not made before rupture, presumably because of the nonspecific
symptoms. Rupture was observed particularly with aortic, pul-
monary, and cerebral artery involvement.
Treatment of Candida arteritis in most cases included a com-
bination of different antifungal agents and surgery. In the ab-
sence of controlled studies, the optimal choice and duration of
antifungal therapy is unknown. Prolonged, often lifelong ther-
apy has been used, particularly for patients with prosthetic graft
infection. The optimal surgical approach is also not well es-
tablished but may include excision of all infected tissue and
vascular reconstruction, often using extra-anatomic bypass or,
more recently, in situ vascular grafting, particularly with aortic
infection.
Because Candida arteritis is an infrequent entity, a high index
of suspicion, early diagnosis, and prompt antifungal and sur-
gical treatment seem crucial to the effort to avoid arterial rup-
ture. Major hemorrhage can be a life-threatening complication,
well recorded in the SOT setting and frequently complicating
the course of Candida arteritis in patients who have not un-
dergone SOT.
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